肺动脉高压患者外周静脉血氧饱和度与血流动力学参数的相关性
该研究回顾性分析77例经右心导管确诊的肺动脉高压患者,探讨外周静脉血氧饱和度(SpvO2)与混合静脉血氧饱和度(SvO2)、肺血管阻力(PVR)及心指数(CI)等的相关性。结果显示SpvO2与SvO2、CI、PaO2正相关,与PVR等负相关;SpvO2<65%组右心扩大更显著、心功能更差、CI更低、PVR更高。结论认为SpvO2与SvO2一致性较好,可间接反映CI、PVR及右心结构改变,低SpvO2提示病情重、预后不良。
要点
- SpvO2与SvO2一致性较好,可替代反映混合静脉血氧饱和度。
- SpvO2<65%提示右心扩大、心功能差、CI低及PVR高。
- SpvO2可用于临床预测PH患者CI、PVR及预后。
核心结论
- SpvO2与SvO2有较好一致性,并可间接反映PH患者CI、PVR及右心结构改变。
- 低SpvO2提示病情严重、预后不良。
研究设计与样本
- 回顾性分析2015年7月至2016年10月广州呼吸疾病研究所经右心导管确诊的PH住院患者77例,男39例、女38例,年龄19~88岁,平均(52±15)岁。
- 以SpvO2≥65%为界值分为SpvO2≥65%组36例与SpvO2<65%组41例。
- 收集右心导管术时SvO2、SpvO2、心排量及mPAP等参数,计算CI和PVR等,并进行相关性分析。
主要发现
- SpvO2与SvO2、CI、PaO2呈正相关(均P<0.05),与PVR、全肺阻力、体循环阻力、右心房直径和右心室直径呈负相关(P<0.05)。
- SpvO2<65%组右心室和右心房舒张末期直径分别为(32±10)和(47±13) mm,SpvO2≥65%组分别为(28±6)和(41±8) mm。
- SpvO2<65%组WHO心功能分级Ⅲ、Ⅳ级比例(31/41)高于SpvO2≥65%组(10/36)。
- SpvO2<65%组CI为(2.4±1.0),体循环收缩压和平均压为(110±19)和(82±14) mmHg,均低于SpvO2≥65%组[CI(3.3±1.2),收缩压和平均压(122±22)和(90±17) mmHg]。
- SpvO2<65%组PVR[(11±7) Wood U]高于SpvO2≥65%组[(7±5) Wood U,均P<0.05]。
关键数值与推荐
- 以SpvO2≥65%作为分组界值,SpvO2<65%提示病情更重。
- SpvO2与SvO2、CI、PaO2正相关(P<0.05),与PVR、全肺阻力、体循环阻力、右心房直径和右心室直径负相关(P<0.05)。
临床怎么用
- 临床可通过SpvO2间接评估PH患者CI、PVR及右心结构改变。
- SpvO2较低提示病情差、预后不良,可作为预后参考指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the correlation of peripheral venous oxygen saturation (SpvO(2)) with mixed venous oxygen saturation (SvO(2)), pulmonary vascular resistance (PVR) and cardiac index (CI) in patients with pulmonary hypertension (PH), in order to predict these parameters using SpvO(2) and assess the prognosis of patients. Methods: Hospitalized patients diagnosed with PH by right heart catheterization in the Guangzhou Institute of Respiratory Diseases from July 2015 to October 2016 were retrospectively analyzed. Parameters during the right heart catheterization, including SvO(2,)SpvO(2,)cardiac output (CO) and mean pulmonary arterial pressure (mPAP) were recorded, while CI, PVR and other parameters were indirectly calculated. The correlation between SpvO(2) and SvO(2,)CO, CI, mPAP, PVR and other parameters were respectively analyzed and compared between groups. Results: A total of 77 PH patients were selected, which comprised of 39 males and 38 females. The results revealed that SpvO(2) was correlated positively with SvO(2,)CI and PaO(2) (P<0.05), but negatively with PVR, total pulmonary resistance (TPR), systemic vascular resistance, right atrial diameter and right ventricular diameter (P<0.05). In the group with SpvO(2) <65%, the dilation of the right atrium and right ventricle was more significant, the WHO heart function grade was worse, CI, systemic systolic pressure and mean systemic pressure were lower, and PVR and TPR were higher, as compared to those in the group with SpvO(2) ≥65%. (P<0.05). Conclusions: There was good consistency between SpvO(2) and SvO(2). Furthermore, SpvO(2) could indirectly reflect the CI, PVR and changes in right heart structure of PH patients, providing reference for the clinical prediction of CI and PVR, as well as the prognosis of PH patients, through the use of SpvO(2). Low SpvO(2) indicated a severe condition and poor prognosis. 目的: 探讨肺动脉高压(PH)患者外周静脉血氧饱和度(SpvO(2))与混合静脉血氧饱和度(SvO(2))、肺血管阻力(PVR)及心指数等参数的相关性。 方法: 回顾分析2015年7月至2016年10月广州呼吸疾病研究所经右心导管术检查确诊PH的住院患者77例,其中男39例,女38例,年龄19~88岁,平均(52±15)岁。以SpvO(2) ≥65%作为界值将患者分为SpvO(2) ≥65%组(36例)与SpvO(2)< 65%组(41例)。收集右心导管术时SvO(2)、SpvO(2)、心排量及平均肺动脉压(mPAP)等参数,计算心排量指数(CI)和PVR等。将SpvO(2)分别与SvO(2)、心排量、CI、mPAP及PVR等参数进行相关性分析。 结果: SpvO(2)<65%组患者右心室和右心房舒张末期直径分别为(32±10)和(47±13) mm,SpvO(2) ≥65%组分别为(28±6)和(41±8) mm;SpvO(2)<65%组患者世界卫生组织心功能分级Ⅲ、Ⅳ级比例(31/41)高于SpvO(2) ≥65%组(10/36),SpvO(2) <65%组CI为(2.4±1.0),体循环收缩压和平均压为(110±19)和(82±14) mmHg(1 mmHg=0.133 kPa),均低于SpvO(2) ≥65%组[CI为(3.3±1.2),体循环收缩压和平均压为(122±22)和(90±17) mmHg],PVR[(11±7) Wood U]高于SpvO(2) ≥65%组[(7±5) Wood U,均P<0.05]。本组患者中SpvO(2)与SvO(2)、CI、PaO(2)呈正相关(均P<0.05),与PVR、全肺阻力、体循环阻力、右心房直径和右心室直径呈负相关(P<0.05)。 结论: SpvO(2)与SvO(2)有较好的一致性;SpvO(2)还可间接反应PH患者心指数、肺血管阻力及右心结构的改变。SpvO(2)可用于预测PH患者心指数、肺血管阻力及预后;SpvO(2)较低提示病情差,预后不良。.
引用
- Hong C, Li JY, Chen RK, et al. [Correlation between peripheral venous oxygen saturation and hemodynamic parameters in patients with pulmonary hypertension]. Zhonghua Jie He He Hu Xi Za Zhi. 2018. PMID: 29343014. doi:10.3760/cma.j.issn.1001-0939.2018.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。